1,199 Intuitive Surgical, Inc. $ISRG Shares Sold by Cabot Wealth Management Inc.

Cabot Wealth Management Inc. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,916 shares of the medical equipment provider’s stock after selling 1,199 shares during the quarter. Cabot Wealth Management Inc.’s holdings in Intuitive Surgical were worth $1,186,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the company. North Point Portfolio Managers Corp OH acquired a new position in Intuitive Surgical in the 3rd quarter valued at $27,000. John Boyer Inc. bought a new position in Intuitive Surgical during the 3rd quarter worth $27,000. Compass Wealth Management LLC bought a new position in Intuitive Surgical during the 3rd quarter worth $29,000. Main Street Group LTD bought a new position in Intuitive Surgical during the 1st quarter worth $30,000. Finally, Compass Financial Management LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. KeyCorp reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 21st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $449.53 on Thursday. The company has a market capitalization of $155.83 billion, a P/E ratio of 54.36, a P/E/G ratio of 3.10 and a beta of 1.45. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The business’s 50 day simple moving average is $414.76 and its 200 day simple moving average is $430.83.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company’s revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the company earned $2.40 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, Director Craig Barratt sold 1,150 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the sale, the director directly owned 1,150 shares of the company’s stock, valued at approximately $529,000. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at $464,993.46. The trade was a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 39,056 shares of company stock worth $17,585,864 in the last quarter. 0.60% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.